Letter by Groothof et al Regarding Article, "Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial". Issue 2 (12th July 2022) - Groothof, Dion; Post, Adrian; Bakker, Stephan J.L.